06.04.21

Kala Pharmaceuticals Announces Eysuvis Now Covered by OptumRx

05.14.21

ReGenTree Announces Additional Results From ARISE-3 Trial Using RGN-259 for the Treatment of Dry Eye

Source: ReGenTree

04.16.21

Quantel Medical Launches Dry Eye Information Website for Patients

Source: Quantel Medical

04.12.21

Allergan Launches New Consumer Ad Campaign for Restasis

Source: Allergan

03.26.21

Oasis Medical Launches Cyber Platform MY OASIS to Support Dry Eye Clinics

Source: Oasis Medical

03.16.21

Kala Pharmaceuticals Announces Preferred Position for Eysuvis on Cigna

Source: Kala Pharmaceuticals

02.04.21

Surface Ophthalmics Announces First Patient Dosed in Phase 2 Trial for SURF-200 for Acute Dry Eye

Source: Surface Ophthalmics

01.21.21

Preliminary Results From Aldeyra’s Phase 3 Tranquility Trial Offer Promise for Patients With Dry Eye Syndrome, Says GlobalData

Source: GlobalData

12.01.20

Alcon Canada to Launch a Professional Line of Systane Ultra Hydration Lubricant Eye Drops Preservative Free

Source: Alcon

11.24.20

Report: Dry Eye Treatment Devices Market Size Worth $400.8 Million By 2027

Source: Grand View Research, Inc.

View more stories